These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 16689553)

  • 1. Ecopharmacology: a new topic of importance in pharmacovigilance.
    Kümmerer K; Velo G
    Drug Saf; 2006; 29(5):371-3. PubMed ID: 16689553
    [No Abstract]   [Full Text] [Related]  

  • 2. Environmental pharmacology: source, impact and solution.
    Jena M; Mishra A; Maiti R
    Rev Environ Health; 2019 Mar; 34(1):69-79. PubMed ID: 30854834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Research progress of pharmaceutical and personal care products on ecological and human health].
    Liu Y; Zhu L; Li J
    Wei Sheng Yan Jiu; 2009 Mar; 38(2):237-40. PubMed ID: 19408672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hurdles of environmental risk assessment procedures for advanced therapy medicinal products: comparison between the European Union and the United States.
    Iglesias-Lopez C; Obach M; Vallano A; Agustí A; Montané J
    Crit Rev Toxicol; 2019 Aug; 49(7):580-596. PubMed ID: 31846383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Issues with regulatory pharmacovigilance in East European countries: the industry perspective.
    Hanzl-Dujmović I; Sulić-Milisić Z; Staresinić-Sernhorst I
    Toxicol Lett; 2007 Feb; 168(3):228-35. PubMed ID: 17161561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The environmental risk assessment of human pharmaceuticals in the overall EU regulatory affairs process.
    Laenge R; Steger-Hartmann T; Schweinfurth H
    Regul Toxicol Pharmacol; 2006 Aug; 45(3):223-8. PubMed ID: 16716476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Environmental risk assessment for new human pharmaceuticals in the European Union according to the draft guideline/discussion paper of January 2001.
    Straub JO
    Toxicol Lett; 2002 Oct; 135(3):231-7. PubMed ID: 12270681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Environmental risk assessment for new human pharmaceuticals in the European Union according to the draft guideline/discussion paper of January 2001.
    Straub JO
    Toxicol Lett; 2002 May; 131(1-2):137-43. PubMed ID: 11988366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ability of Primary Care Health Databases to Assess Medicinal Products Discussed by the European Union Pharmacovigilance Risk Assessment Committee.
    Flynn R; Hedenmalm K; Murray-Thomas T; Pacurariu A; Arlett P; Shepherd H; Myles P; Kurz X
    Clin Pharmacol Ther; 2020 Apr; 107(4):957-965. PubMed ID: 31955404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeating history: pharmaceuticals in the environment.
    Ankley GT; Brooks BW; Huggett DB; Sumpter JP
    Environ Sci Technol; 2007 Dec; 41(24):8211-7. PubMed ID: 18200843
    [No Abstract]   [Full Text] [Related]  

  • 11. EUROmediCAT Recommendations for European Pharmacovigilance concerning safety of medication use in pregnancy.
    EUROmediCAT Steering Group
    Pharmacoepidemiol Drug Saf; 2015 Oct; 24 Suppl 2():3-7. PubMed ID: 26395593
    [No Abstract]   [Full Text] [Related]  

  • 12. Science and regulation. New science for chemicals policy.
    Schwarzman MR; Wilson MP
    Science; 2009 Nov; 326(5956):1065-6. PubMed ID: 19965413
    [No Abstract]   [Full Text] [Related]  

  • 13. Targeted eco-pharmacovigilance as an optimized management strategy for adverse effects of pharmaceuticals in the environment.
    Wang J; Li S; Zhu Y; Guo J; Liu J; He B
    Environ Toxicol Pharmacol; 2021 Feb; 82():103565. PubMed ID: 33321209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving pharmacovigilance in Europe.
    Moore N; Bégaud B
    BMJ; 2010 Apr; 340():c1694. PubMed ID: 20385717
    [No Abstract]   [Full Text] [Related]  

  • 15. International Conference on Harmonisation; guidance on E2E Pharmacovigilance Planning; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2005 Apr; 70(62):16827-8. PubMed ID: 15803631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacoenvironmentology--a component of pharmacovigilance.
    Rahman SZ; Khan RA; Gupta V; Uddin M
    Environ Health; 2007 Jul; 6():20. PubMed ID: 17650313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ecotoxicological aspects related to the presence of pharmaceuticals in the aquatic environment.
    Santos LH; Araújo AN; Fachini A; Pena A; Delerue-Matos C; Montenegro MC
    J Hazard Mater; 2010 Mar; 175(1-3):45-95. PubMed ID: 19954887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aggregate analysis of regulatory authority assessors' comments to improve the quality of periodic safety update reports.
    Jullian S; Jaskiewicz L; Pfannkuche HJ; Parker J; Lalande-Luesink I; Lewis DJ; Close P
    Pharmacoepidemiol Drug Saf; 2015 Sep; 24(9):971-9. PubMed ID: 26175055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [How does a new medicine reach the patient?].
    Visser BJ; Korevaar DA; Mokhles MM; Vermeer-Pragt W; de Boer A; Giezen TJ
    Ned Tijdschr Geneeskd; 2020 Jul; 164():. PubMed ID: 32779914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ecotoxicology--a multidisciplinary, problem-driven science.
    Hermens JL; Ankley GT; Sumpter JP
    Environ Sci Technol; 2004 Dec; 38(23):446A-447A. PubMed ID: 15597863
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.